Gabriel Wasinger

This study uses advanced human co-culture models to show that fibroblast-derived thrombospondin-1 drives macrophage metabolic remodeling and polarization in tumor environments.

This study establishes a murine tumoroid biobank to identify oncogenic pathways and drug vulnerabilities in prostate cancer, finding that PTEN loss drives cancer pathways and that specific compounds inhibit tumor growth.

This study identifies TRβ as a driver of prostate cancer growth and shows that NH-3 inhibits PCa cell proliferation and tumor growth, particularly in castration-resistant models.

This study identifies biomarkers and trajectories of prostate cancer progression using bioinformatics fusion of weighted correlation network analysis and machine learning, finding the EZH2-TROAP axis as a key trajectory and 58 validated biomarkers.